PPARGC1A and sarcopenia: The treatment with recombinant sestrin2 increased the phospho-S6K1 level in the two genotypes, thus supporting the role of PGC-1α in the sestrin2-mediated messenger target of the rapamycin complex 1 pathway regulation of mitochondrial function in sarcopenia.